Udg Healthcare (LON:UDG)‘s stock had its “buy” rating reaffirmed by investment analysts at Liberum Capital in a research report issued on Friday, ThisIsMoney.Co.Uk reports.
Several other research analysts have also weighed in on the company. Peel Hunt reaffirmed a “buy” rating on shares of Udg Healthcare in a research report on Thursday. Berenberg Bank lifted their target price on Udg Healthcare from GBX 700 ($9.15) to GBX 850 ($11.11) and gave the company a “hold” rating in a report on Tuesday, August 20th. Royal Bank of Canada downgraded Udg Healthcare to a “sector performer” rating and lowered their price target for the company from GBX 830 ($10.85) to GBX 800 ($10.45) in a research report on Monday, August 12th. Finally, Barclays restated an “overweight” rating and set a GBX 830 ($10.85) price target on shares of Udg Healthcare in a research note on Thursday, November 21st. Four research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. The stock currently has an average rating of “Hold” and an average target price of GBX 858.17 ($11.21).
Shares of UDG opened at GBX 799 ($10.44) on Friday. Udg Healthcare has a fifty-two week low of GBX 545 ($7.12) and a fifty-two week high of GBX 846 ($11.05). The company’s fifty day moving average is GBX 779.18 and its two-hundred day moving average is GBX 761.46. The firm has a market cap of $2.00 billion and a PE ratio of 34.89. The company has a quick ratio of 1.50, a current ratio of 1.59 and a debt-to-equity ratio of 26.65.
Udg Healthcare Company Profile
UDG Healthcare plc, together with its subsidiaries, provides advisory, communication, commercial, clinical, and packaging services in the Republic of Ireland, the United Kingdom, North America, and internationally. The company operates in two segments, Ashfield and Sharp. The Ashfield segment offers commercialization services for the pharmaceutical and healthcare industry in the areas of advisory, communications, and commercial and clinical services.
Further Reading: Accumulation/Distribution
Receive News & Ratings for Udg Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Udg Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.